报价延迟最少15分钟:2025/09/18 14:05 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
177.81 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
9.71/14.25
|
|
企业价值
17.16B
|
| 资产负债 |
|
每股账面净值
122.86
|
| 现金流量 |
|
现金流量率
0.08
|
| 损益表 |
|
收益
1.76B
|
|
每股收益
103.07
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟：2025/09/18 14:05 EDT
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland. |
